Satori Pharmaceuticals Lands $15,000,000 New Financing

  • Feed Type
  • Date
    2/23/2012
  • Company Name
    Satori Pharmaceuticals
  • Mailing Address
    281 Albany Street Cambridge, MA 02139
  • Company Description
    Satori Pharmaceuticals is a neuroscience company focused on the discovery and development of innovative disease-modifying therapies for Alzheimer’s disease, Parkinson’s disease and other neurodegenerative disorders.
  • Website
    http://www.satoripharma.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $15,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    InterWest Partners
  • Venture Investor
    Prospect Venture Partners
  • Venture Investor
    New Enterprise Associates
  • Venture Investor
    Undisclosed

Next Post

Related Topics

Related Posts

Xconomy’s Most Popular

  1. Don’t Panic, But We’ve Passed Peak Apple. And Google. And Facebook.
  2. With Big Bucks Chasing Big Data, Will Consumers Get a Cut?
  3. Profiles in Long-Termism: Sarepta Therapeutics CEO Chris Garabedian
  4. 11 Reasons Why Flickr, Not Facebook, Is the Place to Put Your Photos
  5. Digital Lumens, Finding Its Identity, Brings Cost & Energy Savings to Light

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.